logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hengrui Medicine (01276.HK) spent 25.7996 million yuan to repurchase 488,000 A-shares on August 14.

date
14/08/2026
Zhitong Finance APP reported that Jiangsu Hengrui Medicine (01276.HK) announced that on August 14, 2026, the company spent 25.7996 million yuan to repurchase 488,000 A-shares.
Latest
2 m ago
Yangpu Medical: In the first half of 2026, net profit reached 30.8149 million yuan, a year-on-year increase of 101.85%.
3 m ago
Tongda Hongtai (02363) issued a profit warning, expecting a mid-term net loss of approximately HKD 9.6 million to HKD 9.8 million, a shift from profit to loss compared to the same period last year.
4 m ago
Double Yuan Technology: In the first half of 2026, net profit was 43.6931 million yuan, a year-on-year increase of 19.68%.
4 m ago
Weipai Ge: In the first half of 2026, the net profit loss amounted to 130 million yuan, a year-on-year increase in losses.
4 m ago
Heart Moving Company (02400.HK) spent HKD 7.8774 million on August 14 to repurchase 185,000 shares.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.